Samsung Biologics Co.,Ltd.'s (KRX:207940) P/E Still Appears To Be Reasonable
Sep 07
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Clinical Research and Equipment Industry Analysis
UpdatedSep 27, 2025
DataAggregated Company Financials
Companies27
- 7D-2.7%
- 3M4.1%
- 1Y10.5%
- YTDn/a
The Clinical Research and Equipment is pretty flat in the last 7 days, but Curiox Biosystems has stood out, gaining 10%. As for the the longer term, the industry is up 6.1% over the past 12 months. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the South Korean Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 27 Sep 2025 | ₩85.6t | ₩5.8t | ₩1.2t | 14.4x | 72.2x | 14.7x |
| Mon, 25 Aug 2025 | ₩88.1t | ₩5.8t | ₩1.2t | 24.4x | 72.2x | 15.1x |
| Wed, 23 Jul 2025 | ₩88.8t | ₩5.7t | ₩1.2t | 16.7x | 72.5x | 15.6x |
| Fri, 20 Jun 2025 | ₩82.0t | ₩5.6t | ₩1.2t | 16.8x | 66.5x | 14.6x |
| Sun, 18 May 2025 | ₩82.3t | ₩5.2t | ₩1.0t | 17.5x | 80.2x | 15.8x |
| Tue, 15 Apr 2025 | ₩84.2t | ₩5.2t | ₩1.0t | 17.9x | 81.9x | 16.2x |
| Thu, 13 Mar 2025 | ₩84.9t | ₩5.2t | ₩996.4b | 12.6x | 85.2x | 16.3x |
| Sat, 08 Feb 2025 | ₩91.9t | ₩5.0t | ₩965.6b | 12.5x | 95.2x | 18.3x |
| Mon, 06 Jan 2025 | ₩76.0t | ₩5.0t | ₩965.6b | 13.3x | 78.7x | 15.2x |
| Wed, 04 Dec 2024 | ₩76.8t | ₩5.0t | ₩947.9b | 13.1x | 81x | 15.2x |
| Fri, 01 Nov 2024 | ₩82.5t | ₩4.8t | ₩885.3b | 13.2x | 93.2x | 17x |
| Sun, 29 Sep 2024 | ₩77.5t | ₩4.8t | ₩885.3b | 14.6x | 87.5x | 16x |
| Tue, 27 Aug 2024 | ₩75.6t | ₩4.8t | ₩884.5b | 15.1x | 85.4x | 15.6x |
| Thu, 25 Jul 2024 | ₩70.1t | ₩4.5t | ₩731.7b | 19.4x | 95.7x | 15.4x |
| Sat, 22 Jun 2024 | ₩59.4t | ₩4.6t | ₩691.8b | 18.2x | 85.9x | 12.9x |
| Mon, 20 May 2024 | ₩61.8t | ₩4.4t | ₩663.4b | 20.3x | 93.2x | 14x |
| Wed, 17 Apr 2024 | ₩62.8t | ₩4.7t | ₩654.7b | 18.8x | 95.9x | 13.5x |
| Fri, 15 Mar 2024 | ₩66.3t | ₩4.6t | ₩636.6b | 29.2x | 104.2x | 14.3x |
| Sun, 11 Feb 2024 | ₩63.4t | ₩4.5t | ₩714.4b | 33.8x | 88.8x | 14x |
| Tue, 09 Jan 2024 | ₩59.6t | ₩4.5t | ₩721.5b | 32.7x | 82.6x | 13.1x |
| Thu, 07 Dec 2023 | ₩56.1t | ₩4.5t | ₩721.6b | 31.2x | 77.7x | 12.4x |
| Sat, 04 Nov 2023 | ₩55.4t | ₩4.4t | ₩660.9b | 23.4x | 83.8x | 12.6x |
| Mon, 02 Oct 2023 | ₩54.3t | ₩4.4t | ₩660.9b | 30.3x | 82.1x | 12.3x |
| Wed, 30 Aug 2023 | ₩59.6t | ₩4.4t | ₩693.2b | 29.1x | 85.9x | 13.5x |
| Fri, 28 Jul 2023 | ₩61.3t | ₩4.2t | ₩673.4b | 27.4x | 91x | 14.6x |
| Sun, 25 Jun 2023 | ₩58.2t | ₩4.2t | ₩666.5b | 29.9x | 87.3x | 13.7x |
| Tue, 23 May 2023 | ₩61.1t | ₩4.3t | ₩621.4b | 27.2x | 98.3x | 14.2x |
| Thu, 20 Apr 2023 | ₩61.8t | ₩4.1t | ₩626.3b | 29.8x | 98.6x | 15.1x |
| Sat, 18 Mar 2023 | ₩62.9t | ₩4.0t | ₩715.4b | 26.6x | 87.9x | 15.7x |
| Mon, 13 Feb 2023 | ₩63.1t | ₩3.5t | ₩427.8b | 20.8x | 147.5x | 18.1x |
| Wed, 11 Jan 2023 | ₩62.3t | ₩3.4t | ₩428.7b | 20.6x | 145.2x | 18.1x |
| Fri, 09 Dec 2022 | ₩64.7t | ₩3.4t | ₩428.7b | 19.7x | 150.9x | 18.8x |
| Sun, 06 Nov 2022 | ₩67.1t | ₩3.0t | ₩448.5b | 22.8x | 149.6x | 22.5x |
| Tue, 04 Oct 2022 | ₩62.8t | ₩3.0t | ₩448.5b | 21.9x | 140x | 21x |
Price to Earnings Ratio
140x
Current Industry PE
- Investors are pessimistic on the South Korean Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 73.8x which is lower than its 3-year average PE of 95.6x.
- The industry is trading close to its 3-year average PS ratio of 15.5x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have grown 38% per year over the last three years.
- Revenues for these companies have grown 25% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does South Korean Clinical Research and Equipment compare with similar industries?
| KR Market | -1.80% | |
| Healthcare | -2.69% | |
| Life Sciences | -2.68% | |
| Clinical Research and Equipment | -2.68% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A445680 Curiox Biosystems | ₩62.90k | 10.4% +₩99.6b | 228.8% | PS277.5x | |
| A238120 Aligned Genetics | ₩3.34k | 0.8% +₩351.5m | 7.1% | PE14.2x | |
| A236340 MEDIZEN HUMANCARE | ₩2.00k | 5.3% +₩230.5m | -33.1% | n/a | |
| A215570 Cronex.Co.Ltd | ₩835.00 | 0.4% +₩9.6m | 67.0% | n/a |
